For the first time novel expression sites in the brain have been identified for a gene which is associated with Motor Neuron Disease and Frontotemporal Dementia.
Many people who develop Motor Neuron Disease, also called Amyotropic Lateral Sclerosis (ALS), and/or Frontotemporal Dementia (FTD) have abnormal repeats of nucleotides within a gene called C9orf72 which causes neurons to die.
A team from the Department of Biology & Biochemistry at the University of Bath discovered for the first time that the C9orf72 gene is strongly expressed in the hippocampus of the mouse brain- a region where adult stem cells reside and which is known to be important for memory.
C9orf72 is also expressed at the olfactory bulb, involved in the sense of smell. Loss of smell is sometimes a symptom in FTD.
They also found that the C9orf72 protein changes from being concentrated in the cytoplasm of cells to both the cytoplasm and nucleus as the brain cortex develops, and during the development of neurons.
Dr Vasanta Subramanian, who led the study, said: "By uncovering novel sites of expression in the brain our findings provide an important resource for researchers studying animal models of C9orf72 mediated ALS and FTD.
"It is essential to know in which cell types in the nervous system the C9orf72 gene is expressed and where within the cell the C9orf72 protein is present.
"Our hope is that by researching accurate animal models of these diseases scientists can eventually develop new treatments and eventually cures for these devastating degenerative diseases."
The researchers, Ross Ferguson, Eleni Serafeimidou- Pouliou and Vasanta Subramanian, were working to map expression of C9orf72 in developing and adult mouse brains to help characterise reliable animal models to study the gene and its effects in both kinds of neurodegenerative diseases, for which there are currently no cures.
Dr Brian Dickie, Director of Research Development at the Motor Neurone Disease Association, said: "It is unclear why people who carry an abnormality in genes like c9orf72 don't usually develop symptoms of these diseases until several decades after birth, but it is possible that the activity of the gene early in life somehow 'primes' certain types of neuron to degenerate later in life.
"This detailed study provides a platform for future research to understand the role of this important gene in health and disease."
The exact function of C9orf72 in humans and animals remains unknown, but in the mutated version in patients there are large stretches of abnormal repeated sequences.
Single treatment with CRISPR gene editing therapy offers hope for hereditary angioedema patients